Texas Passes Ibogaine Bill Giving State Role in Psychedelic Drug Development

Texas is making some surprisingly bold moves that should be on every enthusiast's radar. The state legislature just greenlit a massive $50 million plan to dive deep into ibogaine research, targeting serious issues like addiction and mental health. Rather than a simple grant, they’re building a powerhouse consortium of schools and hospitals to chase FDA approval, with Texas keeping a financial stake in the discoveries to help fund veterans' programs.

But that’s not all—Texas is also finally expanding its medical marijuana program to include chronic pain and TBIs. For everyday tokers and patients, this is a massive win because it shows that even in traditional strongholds, the medical potential of these substances is becoming impossible to ignore. It’s a shift from punishment to progress, signaling a future where accessibility is driven by science rather than stigma. This kind of state-backed legitimacy is exactly what we need to see the industry evolve and for patients to finally get the relief they deserve.